Asset Details
Do you wish to reserve the book?
Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
Do you wish to request the book?
Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
2019
Overview
Epicardial adipose tissue (EAT) is part of the visceral adipose tissue (VAT) that surrounds the heart and it is a quantifiable, modifiable, and multifaceted tissue that has both local and systemic effects. When EAT is enlarged, EAT contributes to atherosclerotic cardiovascular disease (ASCVD) risk and plays a role in the development of metabolic syndrome (MetS). In this review, we will discuss the role of EAT in various facets of MetS, including type 2 diabetes mellitus (T2DM) and insulin resistance. We examine the association between EAT and liver steatosis. We also address the correlations of EAT with HIV therapy and with psoriasis. We discuss racial differences in baseline EAT thickness. We conclude that EAT measurement serves as a powerful potential diagnostic tool in assessing cardiovascular and metabolic risk. Measurement of EAT is made less costly, more convenient, and yet accurate and reliable by transthoracic echocardiography. Furthermore, modification of EAT thickness has therapeutic implications for ASCVD, T2DM, and MetS.
Publisher
MDPI AG,MDPI
Subject
/ Body fat
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular Diseases - metabolism
/ Cardiovascular Diseases - pathology
/ Diabetes
/ Glucose
/ Heart
/ Humans
/ Intra-Abdominal Fat - metabolism
/ Intra-Abdominal Fat - pathology
/ Metabolic Syndrome - epidemiology
/ Metabolic Syndrome - metabolism
/ Metabolic Syndrome - pathology
/ Obesity
/ Review
